» Articles » PMID: 17880727

Tissue Distribution of DNA-Hsp65/TDM-loaded PLGA Microspheres and Uptake by Phagocytic Cells

Overview
Publisher Biomed Central
Date 2007 Sep 21
PMID 17880727
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to demonstrate that microspheres, used as delivery vehicle of DNA-Hsp65/TDM [plasmid DNA encoding heat shock protein 65 (Hsp65) coencapsulated with trehalose dimycolate (TDM) into PLGA microspheres], are widely spread among several organs after intramuscular administration in BALB/c mice. In general, we showed that these particles were phagocytosed by antigen presenting cells, such as macrophages and dendritic cells. Besides, it was demonstrated herein that draining lymph node cells presented a significant increase in the number of cells expressing costimulatory molecules (CD80 and CD86) and MHC class II, and also that the administration of the DNA-Hsp65/TDM and vector/TDM formulations resulted in the up-regulation of CD80, CD86 and MHC class II expression when compared to control formulations (vector/TDM and empty). Regarding the intracellular trafficking we observed that following phagocytosis, the microspheres were not found in the late endosomes and/or lysosomes, until 15 days after internalization, and we suggest that these constructions were hydrolysed in early compartments. Overall, these data expand our knowledge on PLGA [poly (lactic-co-glycolic acid)] microspheres as gene carriers in vaccination strategies, as well as open perspectives for their potential use in clinical practice.

Citing Articles

Targeting of sialoadhesin-expressing macrophages through antibody-conjugated (polyethylene glycol) poly(lactic-co-glycolic acid) nanoparticles.

Van Hees S, Elbrink K, De Schryver M, Delputte P, Kiekens F J Nanopart Res. 2022; 24(3):65.

PMID: 35311024 PMC: 8919690. DOI: 10.1007/s11051-022-05451-1.


Immunotherapeutic Activities of a DNA Plasmid Carrying the Mycobacterial hsp65 Gene (DNAhsp65).

Silva C, Malardo T, Carvalho Tahyra A Front Med Technol. 2022; 2:603690.

PMID: 35047886 PMC: 8757890. DOI: 10.3389/fmedt.2020.603690.


Antileishmanial and Immunomodulatory Effect of Babassu-Loaded PLGA Microparticles: A Useful Drug Target to Infection.

Silva M, Brito J, Dos Santos Ferreira A, Vale A, Santos A, Silva L Evid Based Complement Alternat Med. 2018; 2018:3161045.

PMID: 30046335 PMC: 6036798. DOI: 10.1155/2018/3161045.


Targeting the porcine immune system--particulate vaccines in the 21st century.

McCullough K, Summerfield A Dev Comp Immunol. 2008; 33(3):394-409.

PMID: 18771683 PMC: 7103233. DOI: 10.1016/j.dci.2008.07.015.

References
1.
McKeever U, Barman S, Hao T, Chambers P, Song S, Lunsford L . Protective immune responses elicited in mice by immunization with formulations of poly(lactide-co-glycolide) microparticles. Vaccine. 2002; 20(11-12):1524-31. DOI: 10.1016/s0264-410x(01)00509-6. View

2.
Men Y, Audran R, Thomasin C, Eberl G, Demotz S, Merkle H . MHC class I- and class II-restricted processing and presentation of microencapsulated antigens. Vaccine. 1999; 17(9-10):1047-56. DOI: 10.1016/s0264-410x(98)00321-1. View

3.
Desai M, Labhasetwar V, Walter E, Levy R, Amidon G . The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res. 1998; 14(11):1568-73. DOI: 10.1023/a:1012126301290. View

4.
Jilek S, Merkle H, Walter E . DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells. Adv Drug Deliv Rev. 2004; 57(3):377-90. DOI: 10.1016/j.addr.2004.09.010. View

5.
Lunsford L, McKeever U, Eckstein V, Hedley M . Tissue distribution and persistence in mice of plasmid DNA encapsulated in a PLGA-based microsphere delivery vehicle. J Drug Target. 2000; 8(1):39-50. DOI: 10.3109/10611860009009208. View